At $99.25, Novartis stock price remains firmly in its 50-day moving average channel, a positive technical indicator. Fundamental outlook is reinforced by diversified drug portfolio revenue streams. Even so, it always helps to buy shares of strong dividend stocks whose businesses can remain afloat when the economy tanks. Here are two companies that have what it takes: Novartis (NYSE: NVS) and Gilead Sciences (NASDAQ: GILD) . NVS stock has enjoyed a strong uptrend throughout 2025, but the technical setup suggests the stock may be due for a pause or pullback . Shares are currently trading at approximately $128, about 3.5% above the consensus analyst price target , which leaves limited near-term upside. Plus, there's a valuation risk with Novartis trading at a price-to-earnings (P/E) ratio around 15% higher than its historical average. Novartis stock price edged up to $99.75, backed by robust cash flow data and improved guidance. Sector rotation into healthcare continues as macroeconomic uncertainty fuels demand for defensive assets.
Return this item within 90 days of purchase.
Get an immediate answer with AI
AI-generated from the text of manufacturer documentation. To verify or get additional information, please contact The Home Depot customer service.